JOHNSON & JOHNSON

Q3 2021 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Marc Larkins - Secretary
Location
New Brunswick, NJ
Holdings as of
September 30, 2021
Value $
$1.14B
Num holdings
25
Date filed
11/16/2021, 02:21 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Next filing
Q4 2021 - Feb 14, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Matthew Orlando Secretary New Brunswick, New Jersey 11/16/2021

This amendment is being filed solely to include Johnson & Johnson UK Treasury Company Limited as an Included Manager and to indicate in the Information Table that a previously-reported position is held by this Manager.

Other Included Managers (2):

Num Name Location File Number
1 Johnson & Johnson Innovation - JJDC, Inc. New Brunswick, NJ 028-20073
2 Johnson & Johnson UK Treasury Company Limited